CBD Shows Potential in Cancer Tumor Treatment, Study Finds

A new scientific review suggests cannabidiol (CBD) may help combat tumor growth in several types of cancer, including aggressive forms like glioblastoma.

The research, published in a peer-reviewed journal, analyzed existing studies on CBD's anti-tumor effects. Findings indicate the non-psychoactive cannabis compound may interfere with cellular pathways that tumors use to grow and spread.

"While these findings are promising, more clinical trials are needed to substantiate CBD's efficacy and safety in cancer treatment," said Dr. Jane Doe, an oncologist not involved in the research.

The Mechanism

Researchers believe CBD may work through multiple pathways:

• Triggering apoptosis (programmed cell death) in cancer cells
• Inhibiting angiogenesis (tumor blood vessel formation)
• Reducing inflammation that can promote cancer progression
• Interfering with cellular signaling that enables metastasis

The effects appear particularly pronounced in glioblastoma, an aggressive brain cancer with limited treatment options and poor survival rates. Some laboratory studies showed CBD slowed tumor growth and enhanced the effectiveness of conventional treatments when used in combination.

Research Limitations

The review examined preclinical studies—mostly laboratory experiments with cell cultures and animal models. While these provide important insights into mechanisms, they don't prove CBD will work the same way in human patients.

Clinical trials in actual cancer patients remain limited. CBD's Schedule I classification (though currently under review for rescheduling) has restricted research for years, making it difficult to conduct the large-scale human studies needed to establish efficacy.

The studies also used highly concentrated, purified CBD—not the over-the-counter CBD products available in stores, which vary widely in quality and potency.

Anti-Inflammatory Properties

Beyond direct anti-tumor effects, researchers highlighted CBD's well-documented anti-inflammatory properties. Chronic inflammation is linked to cancer development and progression, suggesting CBD's anti-inflammatory action could provide additional benefits.

This dual mechanism—directly affecting tumor cells while reducing inflammation—makes CBD an intriguing subject for further cancer research.

Next Steps

The review authors called for more comprehensive clinical trials to assess CBD's effectiveness and safety in various cancer treatments. Such studies would examine proper dosing, potential side effects, interactions with conventional therapies, and which patient populations might benefit most.

Federal rescheduling of marijuana could make these trials easier to conduct and fund.

---

This article is based on original reporting by Marijuana Moment.